U.S., Nov. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07223216) titled 'Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants' on Oct. 29.
Brief Summary: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMF-650 in Otherwise Healthy Overweight or Obese Participants.
Study Start Date: Oct. 23
Study Type: INTERVENTIONAL
Condition:
Obesity
Intervention:
DRUG: BMF-650
Interventional Product
Recruitment Status: RECRUITING
Sponsor: Biomea Fusion Inc.
Disclaimer: Curated by HT Syndication....